These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 36313572)

  • 1. Annexins and cardiovascular diseases: Beyond membrane trafficking and repair.
    Méndez-Barbero N; San Sebastian-Jaraba I; Blázquez-Serra R; Martín-Ventura JL; Blanco-Colio LM
    Front Cell Dev Biol; 2022; 10():1000760. PubMed ID: 36313572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexins: Involvement in cholesterol homeostasis, inflammatory response and atherosclerosis.
    Méndez-Barbero N; Gutiérrez-Muñoz C; Blázquez-Serra R; Martín-Ventura JL; Blanco-Colio LM
    Clin Investig Arterioscler; 2021; 33(4):206-216. PubMed ID: 33622609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexins - insights from knockout mice.
    Grewal T; Wason SJ; Enrich C; Rentero C
    Biol Chem; 2016 Oct; 397(10):1031-53. PubMed ID: 27318360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexins and disease.
    Hayes MJ; Moss SE
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1166-70. PubMed ID: 15336964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A protein family in atherosclerosis.
    Li YZ; Wang YY; Huang L; Zhao YY; Chen LH; Zhang C
    Clin Chim Acta; 2022 Jun; 531():406-417. PubMed ID: 35562096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexins and Ca2+ handling in the heart.
    Camors E; Monceau V; Charlemagne D
    Cardiovasc Res; 2005 Mar; 65(4):793-802. PubMed ID: 15721859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid.
    Chapman MJ; Zamorano JL; Parhofer KG
    Pharmacol Ther; 2022 Sep; 237():108172. PubMed ID: 35304222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexins: Ca
    Enrich C; Rentero C; Meneses-Salas E; Tebar F; Grewal T
    Adv Exp Med Biol; 2017; 981():351-385. PubMed ID: 29594868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases.
    Liu XM; Du SL; Miao R; Wang LF; Zhong JC
    Heart Fail Rev; 2022 Jan; 27(1):345-355. PubMed ID: 32648149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hypercholesterolemia and development of cardiovascular disorders: Cellular and molecular mechanisms involved in low-grade systemic inflammation and endothelial dysfunction.
    Collado A; Domingo E; Piqueras L; Sanz MJ
    Int J Biochem Cell Biol; 2021 Oct; 139():106066. PubMed ID: 34438057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of annexins in tumour development and progression.
    Mussunoor S; Murray GI
    J Pathol; 2008 Oct; 216(2):131-40. PubMed ID: 18698663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond Self-Recycling: Cell-Specific Role of Autophagy in Atherosclerosis.
    Henderson JM; Weber C; Santovito D
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathology of AtheroThrombosIS (ATIS)].
    Ueda M
    Drugs; 2010 Nov; 70 Suppl 1():3-8. PubMed ID: 20977286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexins and plasma membrane repair.
    Koerdt SN; Ashraf APK; Gerke V
    Curr Top Membr; 2019; 84():43-65. PubMed ID: 31610865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5.
    Laufer EM; Winkens HM; Corsten MF; Reutelingsperger CP; Narula J; Hofstra L
    Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):26-34. PubMed ID: 19182725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexins-Coordinators of Cholesterol Homeostasis in Endocytic Pathways.
    Rentero C; Blanco-Muñoz P; Meneses-Salas E; Grewal T; Enrich C
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexins as Overlooked Regulators of Membrane Trafficking in Plant Cells.
    Konopka-Postupolska D; Clark G
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plaque-targeted, proteolysis-resistant, activatable and MRI-visible nano-GLP-1 receptor agonist targets smooth muscle cell differentiation in atherosclerosis.
    Maiseyeu A; Di L; Ravodina A; Barajas-Espinosa A; Sakamoto A; Chaplin A; Zhong J; Gao H; Mignery M; Narula N; Finn AV; Rajagopalan S
    Theranostics; 2022; 12(6):2741-2757. PubMed ID: 35401813
    [No Abstract]   [Full Text] [Related]  

  • 19. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
    Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
    Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.